Glutathione IV is incorporated into clinical protocols for lupus (SLE), rheumatoid arthritis, MCAS, chronic Lyme disease, ME/CFS, and Long COVID as part of an individualized approach to the oxidative burden associated with these conditions
Regardless of the GLP-1 RA users taking the drug for the purpose of treating diabetes or for weight loss reasons, this statistic still varied considerably between 15%56% in GLP-1 RA users compared to 5%20% in controls not taking the drug (Chang et al
45:2118-2126 [PMC free article: PMC9472498] [PubMed: 35817022] 249
Glenohumeral injections are usually performed for arthritis or frozen shoulder
Pharmacokinetics and safety of PC-SOD, a lecithinized recombinant superoxide dismutase, in healthy Chinese subjects: A phase 1, randomized, placebo-controlled, dose-escalation study
Top investment banks like Goldman Sachs and Bank of America agree with Pot's assessment